The Patent Finder

Assays for Diagnosing and Evaluating Treatment Options for Fabry Disease

BPCR Limited Partnership

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 7 of these applications claim priority to application 60/801,089, filed May 16, 2006. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 7,851,143Assays for Diagnosing and Evaluating Treatment Options for Fabry Disease
In force
 · High confidence
UsedRemaining
BPCR Limited PartnershipIn forceHigh confidence
US 9,000,011Methods for Treatment of Fabry Disease
In force
 · Medium confidence
BPCR Limited PartnershipIn forceMedium confidence
US 9,480,682Methods for Treatment of Fabry Disease
In force
 · Low confidence
BPCR Limited PartnershipIn forceLow confidence
US 9,987,263Methods for Treatment of Fabry Disease
In force
 · Low confidence
BPCR Limited PartnershipIn forceLow confidence
US 10,383,864Methods for Treatment of Fabry Disease
In force
 · Low confidence
BPCR Limited PartnershipIn forceLow confidence
US 10,406,143Methods for Treatment of Fabry Disease
In force (reinstated)
 · Low confidence
BPCR Limited PartnershipIn force (reinstated)Low confidence
US 11,241,422Methods for Treatment of Fabry Disease
In force
 · Low confidence
BPCR Limited PartnershipIn forceLow confidence
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited